|
FAM160B1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.702400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.913590E-01 |
| Normal-vs-Stage2 |
2.776300E-02 |
| Normal-vs-Stage3 |
2.080400E-02 |
| Normal-vs-Stage4 |
4.121100E-03 |
| Stage1-vs-Stage2 |
1.705990E-01 |
| Stage1-vs-Stage3 |
1.490390E-01 |
| Stage1-vs-Stage4 |
5.167700E-02 |
| Stage2-vs-Stage3 |
7.629200E-01 |
| Stage2-vs-Stage4 |
6.760000E-01 |
| Stage3-vs-Stage4 |
4.128600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.567700E-02 |
| Normal-vs-AfricanAmerican |
6.304000E-01 |
| Normal-vs-Asian |
1.148050E-01 |
| Caucasian-vs-AfricanAmerican |
4.870400E-01 |
| Caucasian-vs-Asian |
8.999000E-01 |
| AfricanAmerican-vs-Asian |
4.554800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.278570E-01 |
| Normal-vs-Female |
3.920200E-02 |
| Male-vs-Female |
5.663000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.137200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.868200E-02 |
| Normal-vs-Age(61-80Yrs) |
3.135300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.059800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.167600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.240100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.002000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.710800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.949700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.888620E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.646400E-02 |
| Classical-VS-Follicular |
5.920699999995E-05 |
| Classical-VS-Other |
5.137600E-01 |
| Classical-VS-Normal |
4.124800E-01 |
| Tall-VS-Follicular |
4.341000E-01 |
| Tall-VS-Other |
7.593000E-01 |
| Tall-VS-Normal |
2.145500E-02 |
| Follicular-VS-Other |
4.995600E-01 |
| Follicular-VS-Normal |
4.552900E-04 |
| Other-VS-Normal |
3.161400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.239700E-03 |
| Normal-vs-N1 |
2.021400E-01 |
| N0-vs-N1 |
2.855800E-01 |
|
|
